TITLE

Partners, what Partners? Amylin, Lilly and BI Fight over exenatide Marketing

PUB. DATE
July 2011
SOURCE
Pharmaceutical Representative;Jul2011, Vol. 41 Issue 7, p7
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article offers news briefs in the pharmaceutical industry in the U.S. Array BioPharma Inc. is restructuring to concentrate on the development of its clinical programs. Endo Pharmaceuticals Inc. acquires American Medical Systems Inc., a producer of medical devices and therapies. GlaxoSmithKline agrees to acquire the remaining 51% equity interest of Shenzhen Neptunus Interlong Bio-Technique Co. Ltd..
ACCESSION #
63483062

 

Related Articles

  • NEWS BRIEFS.  // MondayMorning;6/15/2009, Vol. 17 Issue 22, p5 

    The article presents news briefs related to the pharmaceutical industry. GlaxoSmithKline PLC has forged an alliance with Shenzhen Neptunus to make flu vaccines for China. Analysts have stated that GlaxoSmithKline PLC's experimental diabetes drug Syncria seems comparable to but not significantly...

  • World Briefs.  // Pharmaceutical Technology;Jan2009, Vol. 33 Issue 1, p22 

    The article offers news briefs related to pharmaceutical industry. Shenzhen Neptunus Interlong Bio-Technique Co. Ltd. and GlaxoSmithKline have signed an exclusive cooperation contract toward a planned joint venture. AstraZeneca PLC has introduced manufacturing processes and plans to establish a...

  • Infectious Diseases News Round-up.  // PharmaWatch: Monthly Review;Jan2009, Vol. 8 Issue 1, p17 

    The article offers information related to the treatment of infectious disease. GlaxoSmithKline has partnered with Shenzhen Neptunus Interlong Bio-Technique Co. Ltd. to co-develop seasonal influenza vaccines and pre-pandemic or pandemic influenza vaccines. Lentigen and a non-profit global health...

  • Infectious Diseases.  // PharmaWatch: Monthly Review;Jul2009, Vol. 8 Issue 7, p32 

    The article offers world news briefs related to the infectious diseases segment of the pharmacological industry. The U.S. government has placed a contract for swine flu vaccine development with various companies including GlaxoSmithKline (GSK) and Sanofi Pasteur Inc. GSK and Shenzhen Neptunus...

  • Embrex and Shenzen collaborate on new flu vaccine.  // Pharmaceutical Technology Europe;Nov2006, Vol. 18 Issue 11, p17 

    The article reports on the collaboration of North Carolina-based agricultural firm Embrex Inc. and Shenzen Neptunus Interlong Bio-Tech Co. Ltd. in Shenzhen, Guangdong Sheng, China. The two companies worked together in manufacturing advanced human influenza vaccine. In its collaboration, Embrex...

  • Synergen lineage may finally pay off. Alper, Joseph // Nature Biotechnology;Mar1999, Vol. 17 Issue 3, p217 

    Reports on the business performance of Boulder, Colorado-based Array BioPharma Inc. as of March 1999. Corporate background of Array; Business strategies adopted by Array to generate income in the short term; Analysts' assessment of Array's business strategies.

  • TOP STORIES.  // MondayMorning;12/8/2014, Vol. 22 Issue 45, p1 

    The article offers U.S. new briefs as of December 8, 2014. The restructing process of the pharmaceutical company GlaxoSmithKline PLC will cut the jobs of 17,000 U.S.-based employees. Otsuka Pharmaceutical Co. Ltd, is buying Avanir Pharmaceuticals Inc. for 3.5 billion dollar. Array Biopharma Inc....

  • ARRAY BIOPHARMA REPORTS 3RD QTR NET LOSS OF 14 MILLION.  // Biotech Financial Reports;Jun2007, Vol. 14 Issue 6, p3 

    The article reports that Array Biopharma Inc., a biopharmaceutical company, has revealed net loss of $14 million in financial assets for the third quarter of fiscal 2007 in Boulder, Colorado. Array's revenue has decreased from $11.7 million in 2006 to $10.4 million in 2007. The revenue results...

  • CLINIC ROUNDUP.  // BioWorld Today;6/21/2007, Vol. 18 Issue 120, p6 

    This section offers news briefs related to the pharmaceutical industry. Alexza Pharmaceuticals Inc. has begun a Phase IIa proof-of-concept trial with AZ-104 in patients with migraine headache. Altus Pharmaceuticals Inc. presented an investigational new drug application for ALTU- 237, a...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics